Backlash against Johnson & Johnson’s COVID-19 vaccine is real and risky – here’s how to make its rollout a success
Medical workforce data shortage hampering access to care
8 March 2021Immune cells in cerebrospinal fluid predict response to immunotherapy
8 March 2021Backlash against Johnson & Johnson’s COVID-19 vaccine is real and risky – here’s how to make its rollout a success
More than 50 million Americans have received at least one dose of either the Pfizer or Moderna COVID-19 vaccine. So far, Americans have been largely brand-agnostic, but that’s about to change as a new vaccine rolls out.
